A closer look at paroxysmal nocturnal hemoglobinuria

European Journal of Internal Medicine

Volumn 21, Issue 4, 2010, Pages 260-267

  Rachidi, Saleh ^a   Musallam, Khaled M ^a   Taher, Ali T ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Aplastic anemia; Bone marrow failure; Hemolysis; Paroxysmal nocturnal hemoglobinuria; Thrombosis

Indexed keywords

ANDROGEN; ANTICOAGULANT AGENT; CYCLOSPORIN; ECULIZUMAB; ERYTHROPOIETIN; FOLIC ACID; GLUCOCORTICOID; HEMOGLOBIN; HEPARIN; IRON; LOW MOLECULAR WEIGHT HEPARIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; THYMOCYTE ANTIBODY; WARFARIN; MONOCLONAL ANTIBODY;

ANTICOAGULANT THERAPY; ANTICOAGULATION; APLASTIC ANEMIA; BLOOD TRANSFUSION; BONE MARROW DEPRESSION; CANCER INCIDENCE; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; GRAFT VERSUS HOST REACTION; GRANULOCYTOPENIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBIN DETERMINATION; HEMOLYSIS; HUMAN; HYPERCOAGULABILITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; IRON DEFICIENCY ANEMIA; KAPLAN MEIER METHOD; NONHUMAN; OUTCOME ASSESSMENT; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; RHEUMATOID ARTHRITIS; SERUM SICKNESS; SOMATIC MUTATION; STEROID THERAPY; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; ANEMIA, HEMOLYTIC; BLOOD CLOTTING; BLOOD COAGULATION DISORDERS; COMPLICATION; GENETICS; HEMOGLOBINURIA, PAROXYSMAL; KIDNEY DISEASES; PHYSIOLOGY;

ANEMIA, HEMOLYTIC; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; HEMOGLOBINURIA, PAROXYSMAL; HEMOLYSIS; HUMANS; KIDNEY DISEASES; PROGNOSIS; THROMBOSIS;

EID: 77955318717     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.04.002     Document Type: Short Survey

References (130)

1. W.F. Rosse Paroxysmal nocturnal hemoglobinuria as a molecular disease Medicine (Baltimore) 76 1997 63 93
2. R.P. de Latour, J.Y. Mary, C. Salanoubat, L. Terriou, G. Etienne, and M. Mohty Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories Blood 112 2008 3099 3106
3. A. Hill, P.J. Platts, A. Smith, S.J. Richards, M.J. Cullen, and Q.A. Hill The incidence and prevalence of paroxysmal nocturnal haemoglobinuria (PNH) and survival of patients in Yorkshire [abstract] Haematologica 92 2007 25
4. C. Parker, M. Omine, S. Richards, J. Nishimura, M. Bessler, and R. Ware Diagnosis and management of paroxysmal nocturnal hemoglobinuria Blood 106 2005 3699 3709
5. T. Miyata, J. Takeda, Y. Iida, N. Yamada, N. Inoue, and M. Takahashi The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis Science 259 1993 1318 1320
6. T. Kinoshita, K. Ohishi, and J. Takeda GPI-anchor synthesis in mammalian cells: genes, their products, and a deficiency J Biochem 122 1997 251 257
7. M. Tomita Biochemical background of paroxysmal nocturnal hemoglobinuria Biochim Biophys Acta 1455 1999 269 286
8. V. Rosti The molecular basis of paroxysmal nocturnal hemoglobinuria Haematologica 85 2000 82 87
9. R. Kelly, S. Richards, P. Hillmen, and A. Hill The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab Ther Clin Risk Manag 5 2009 911 921
10. J.P. Maciejewski, E.M. Sloand, T. Sato, S. Anderson, and N.S. Young Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone Blood 89 1997 1173 1181
11. B. Rotoli, R. Robledo, and L. Luzzatto Decreased number of circulating BFU-Es in paroxysmal nocturnal hemoglobinuria Blood 60 1982 157 159
12. N.S. Young The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated Blood 79 1992 1385 1392
13. L. Luzzatto, and M. Bessler The dual pathogenesis of paroxysmal nocturnal hemoglobinuria Curr Opin Hematol 3 1996 101 110
14. D.J. Araten, K. Nafa, K. Pakdeesuwan, and L. Luzzatto Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals Proc Natl Acad Sci U S A 96 1999 5209 5214
15. Y. Murakami, T. Kinoshita, Y. Maeda, T. Nakano, H. Kosaka, and J. Takeda Different roles of glycosylphosphatidylinositol in various hematopoietic cells as revealed by a mouse model of paroxysmal nocturnal hemoglobinuria Blood 94 1999 2963 2970
16. G. Tremml, C. Dominguez, V. Rosti, Z. Zhang, P.P. Pandolfi, and P. Keller Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene Blood 94 1999 2945 2954
17. T. Kawaguchi, and H. Nakakuma New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria Int J Hematol 86 2007 27 32
18. C. Sugimori, T. Chuhjo, X. Feng, H. Yamazaki, A. Takami, and M. Teramura Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia Blood 107 2006 1308 1314
19. B. Hertenstein, B. Wagner, D. Bunjes, C. Duncker, A. Raghavachar, and R. Arnold Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma Blood 86 1995 1487 1492
20. N. Hanaoka, T. Kawaguchi, K. Horikawa, S. Nagakura, H. Mitsuya, and H. Nakakuma Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP Blood 107 2006 1184 1191
21. Y. Murakami, H. Kosaka, Y. Maeda, J. Nishimura, N. Inoue, and K. Ohishi Inefficient response of T lymphocytes to glycosylphosphatidylinositol anchor-negative cells: implications for paroxysmal nocturnal hemoglobinuria Blood 100 2002 4116 4122
22. R.A. Brodsky, M.S. Vala, J.P. Barber, M.E. Medof, and R.J. Jones Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuria Proc Natl Acad Sci U S A 94 1997 8756 8760
23. W.J. Savage, J.P. Barber, G.L. Mukhina, R. Hu, G. Chen, and W. Matsui Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH Exp Hematol 37 2009 42 51
24. H. Szpurka, A.E. Schade, A.M. Jankowska, and J.P. Maciejewski Altered lipid raft composition and defective cell death signal transduction in glycosylphosphatidylinositol anchor-deficient PIG-A mutant cells Br J Haematol 142 2008 413 422
25. S.M. Lewis, and J.V. Dacie Neutrophil (leucocyte) alkaline phosphatase in paroxysmal nocturnal haemoglobinuria Br J Haematol 11 1965 549 556
26. J.V. Auditore, R.C. Hartmann, J.M. Flexner, and O.J. Balchum The erythrocyte acetylcholinesterase enzyme in paroxysmal nocturnal hemoglobinuria Arch Pathol 69 1960 534 543
27. W.F. Rosse, and L.A. Gutterman The effect of iron therapy in paroxysmal nocturnal hemoglobinuria Blood 36 1970 559 565
28. N. Hanaoka, H. Nakakuma, K. Horikawa, S. Nagakura, Y. Tsuzuki, and M. Shimanuki NKG2D-mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes Br J Haematol 146 2009 538 545
29. W.F. Rosse Variations in the red cells in paroxysmal nocturnal haemoglobinuria Br J Haematol 24 1973 327 342
30. W.F. Rosse, and J.V. Dacie Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody J Clin Invest 45 1966 736 748
31. W.F. Rosse, and J. Nishimura Clinical manifestations of paroxysmal nocturnal hemoglobinuria: present state and future problems Int J Hematol 77 2003 113 120
32. M.J. Telen, and A.M. Green The Inab phenotype: characterization of the membrane protein and complement regulatory defect Blood 74 1989 437 441
33. M. Yamashina, E. Ueda, T. Kinoshita, T. Takami, A. Ojima, and H. Ono Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria N Engl J Med 323 1990 1184 1189
34. K.K. Hamilton, R. Hattori, C.T. Esmon, and P.J. Sims Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex J Biol Chem 265 1990 3809 3814
35. P.J. Sims, E.M. Faioni, T. Wiedmer, and S.J. Shattil Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity J Biol Chem 263 1988 18205 18212
36. P.J. Sims, T. Wiedmer, C.T. Esmon, H.J. Weiss, and S.J. Shattil Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity J Biol Chem 264 1989 17049 17057
37. G.E. Gilbert, P.J. Sims, T. Wiedmer, B. Furie, B.C. Furie, and S.J. Shattil Platelet-derived microparticles express high affinity receptors for factor VIII J Biol Chem 266 1991 17261 17268
38. T. Wiedmer, S.E. Hall, T.L. Ortel, W.H. Kane, W.F. Rosse, and P.J. Sims Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria Blood 82 1993 1192 1196
39. J.T. Harmon, and G.A. Jamieson Activation of platelets by alpha-thrombin is a receptor-mediated event. d-Phenylalanyl-l-prolyl-l-arginine chloromethyl ketone-thrombin, but not N alpha-tosyl-l-lysine chloromethyl ketone-thrombin, binds to the high affinity thrombin receptor J Biol Chem 261 1986 15928 15933
40. S. Saadi, R.A. Holzknecht, C.P. Patte, D.M. Stern, and J.L. Platt Complement-mediated regulation of tissue factor activity in endothelium J Exp Med 182 1995 1807 1814
41. M. Ploug, T. Plesner, E. Ronne, V. Ellis, G. Hoyer-Hansen, and N.E. Hansen The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria Blood 79 1992 1447 1455
42. E.M. Sloand, L. Pfannes, P. Scheinberg, K. More, C.O. Wu, and M. Horne Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients Exp Hematol 36 2008 1616 1624
43. R.A. Brodsky How I treat paroxysmal nocturnal hemoglobinuria Blood 113 2009 6522 6527
44. T. Ham Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria: a study of the mechanism of hemolysisin relation to acid-base equilibrium N Engl J Med 217 1937 915 917
45. R.C. Hartmann, and D.E. Jenkins The "sugar-water" test for paroxysmal nocturnal hemoglobinuria N Engl J Med 275 1966 155 157
46. M. Bessler, and J. Fehr Fc III receptors (FcRIII) on granulocytes: a specific and sensitive diagnostic test for paroxysmal nocturnal hemoglobinuria (PNH) Eur J Haematol 47 1991 179 184
47. S.E. Hall, and W.F. Rosse The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria Blood 87 1996 5332 5340
48. P.M. Hernandez-Campo, J. Almeida, M.J. Acevedo, M.L. Sanchez, I. Alberca, and B. Vidriales Detailed immunophenotypic characterization of different major and minor subsets of peripheral blood cells in patients with paroxysmal nocturnal hemoglobinuria Transfusion 48 2008 1403 1414
49. R.A. Brodsky, G.L. Mukhina, S. Li, K.L. Nelson, P.L. Chiurazzi, and J.T. Buckley Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin Am J Clin Pathol 114 2000 459 466
50. R.E. Ware, C.V. Pickens, C.M. DeCastro, and T.A. Howard Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes Exp Hematol 29 2001 1403 1409
51. A. Traulsen, J.M. Pacheco, and D. Dingli On the origin of multiple mutant clones in paroxysmal nocturnal hemoglobinuria Stem Cells 25 2007 3081 3084
52. R. Hu, G.L. Mukhina, S. Piantadosi, J.P. Barber, R.J. Jones, and R.A. Brodsky PIG-A mutations in normal hematopoiesis Blood 105 2005 3848 3854
53. C. Couturier, N. Haeffner-Cavaillon, M. Caroff, and M.D. Kazatchkine Binding sites for endotoxins (lipopolysaccharides) on human monocytes J Immunol 147 1991 1899 1904
54. D.L. Simmons, S. Tan, D.G. Tenen, A. Nicholson-Weller, and B. Seed Monocyte antigen CD14 is a phospholipid anchored membrane protein Blood 73 1989 284 289
55. W.F. Rosse The life-span of complement-sensitive and -insensitive red cells in paroxysmal nocturnal hemoglobinuria Blood 37 1971 556 562
56. J.M. Navenot, J.Y. Muller, and D. Blanchard Investigation of the survival of paroxysmal nocturnal hemoglobinuria red cells through the immunophenotyping of reticulocytes Transfusion 38 1998 337 342
57. H. Ninomiya, T. Abe, and T. Fujita Prolongation of red-cell life-span by incorporation of decay-accelerating factor (DAF) into red cells of paroxysmal nocturnal haemoglobinuria (PNH) Br J Haematol 73 1989 132 133
58. R.K. Nair, A. Khaira, A. Sharma, S. Mahajan, and A.K. Dinda Spectrum of renal involvement in paroxysmal nocturnal hemoglobinuria: report of three cases and a brief review of the literature Int Urol Nephrol 40 2008 471 475
59. M.A. Roubidoux MR of the kidneys, liver, and spleen in paroxysmal nocturnal hemoglobinuria Abdom Imaging 19 1994 168 173
60. D. Mathieu, A. Rahmouni, P. Villeneuve, M.C. Anglade, H. Rochant, and N. Vasile Impact of magnetic resonance imaging on the diagnosis of abdominal complications of paroxysmal nocturnal hemoglobinuria Blood 85 1995 3283 3288
61. M.D. Jose, and K.L. Lynn Acute renal failure in a patient with paroxysmal nocturnal hemoglobinuria Clin Nephrol 56 2001 172 174
62. A. Mooraki, B. Boroumand, F. Mohammad Zadeh, and Bastani B. Ahmed SH Acute reversible renal failure in a patient with paroxysmal nocturnal hemoglobinuria Clin Nephrol 50 1998 255 257
63. L.A. Sechi, A. Marigliano, A. Pala, and R. Tedde Acute renal failure in paroxysmal nocturnal haemoglobinuria with splanchnic venous thromboses Clin Lab Haematol 11 1989 273 275
64. H. Rubin Paroxysmal nocturnal hemoglobinuria with renal failure JAMA 215 1971 433 436
65. D.A. Clark, S.A. Butler, V. Braren, R.C. Hartmann, and D.E. Jenkins Jr The kidneys in paroxysmal nocturnal hemoglobinuria Blood 57 1981 83 89
66. G. Socie, J.Y. Mary, A. de Gramont, B. Rio, M. Leporrier, and C. Rose Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology Lancet 348 1996 573 577
67. P. Hillmen, S.M. Lewis, M. Bessler, L. Luzzatto, and J.V. Dacie Natural history of paroxysmal nocturnal hemoglobinuria N Engl J Med 333 1995 1253 1258
68. W.H. Crosby Paroxysmal nocturnal hemoglobinuria: relation of the clinical manifestations to underlying pathogenic mechanisms Blood 8 1953 769 812
69. V.M. Moyo, G.L. Mukhina, E.S. Garrett, and R.A. Brodsky Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays Br J Haematol 126 2004 133 138
70. J. Nishimura, Y. Kanakura, R.E. Ware, T. Shichishima, H. Nakakuma, and H. Ninomiya Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan Medicine (Baltimore) 83 2004 193 207
71. R.C. Hartmann, A.B. Luther, D.E. Jenkins Jr., L.E. Tenorio, and H.I. Saba Fulminant hepatic venous thrombosis (Budd-Chiari syndrome) in paroxysmal nocturnal hemoglobinuria: definition of a medical emergency Johns Hopkins Med J 146 1980 247 254
72. R. Peytremann, R.S. Rhodes, and R.C. Hartmann Thrombosis in paroxysmal nocturnal hemoglobinuria (PNH) with particular reference to progressive, diffuse hepatic venous thrombosis Ser Haematol 5 1972 115 136
73. J. Hoekstra, F.W. Leebeek, A. Plessier, S. Raffa, S. Darwish Murad, and J. Heller Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study J Hepatol 51 2009 696 706
74. M.A. Doukas, P.E. DiLorenzo, and D.N. Mohler Intestinal infarction caused by paroxysmal nocturnal hemoglobinuria Am J Hematol 16 1984 75 81
75. D. Zimmerman, and W.R. Bell Venous thrombosis and splenic rupture in paroxysmal nocturnal hemoglobinuria Am J Med 68 1980 275 279
76. S.P. Donhowe, and R.P. Lazaro Dural sinus thrombosis in paroxysmal nocturnal hemoglobinuria Clin Neurol Neurosurg 86 1984 149 152
77. F. Omardeen, G. Wharfe, L. St Omer, J.S. Richards, and O.S. Morgan Cerebral sinovenous thrombosis in a patient with paroxysmal nocturnal haemoglobinuria West Indian Med J 41 1992 31 33
78. D. Hauser, N. Barzilai, M. Zalish, M. Oliver, and A. Pollack Bilateral papilledema with retinal hemorrhages in association with cerebral venous sinus thrombosis and paroxysmal nocturnal hemoglobinuria Am J Ophthalmol 122 1996 592 593
79. R.L. Rietschel, C.W. Lewis, R.A. Simmons, and R.L. Phyliky Skin lesions in paroxysmal nocturnal hemoglobinuria Arch Dermatol 114 1978 560 563
80. Z.K. Draelos, and R.C. Hansen Hemorrhagic bullae in an anemic women. Paroxysmal nocturnal hemoglobinuria (PNH) Arch Dermatol 122 1326-7 1986 9 30
81. N.E. Hansen, and S.A. Killmann Paroxysmal nocturnal haemoglobinuria A clinical study. Acta Med Scand 184 1968 525 541
82. H.J. Audebert, J. Planck, M. Eisenburg, H. Schrezenmeier, and R.L. Haberl Cerebral ischemic infarction in paroxysmal nocturnal hemoglobinuria report of 2 cases and updated review of 7 previously published patients J Neurol 252 2005 1379 1386
83. J. Tejada, L. Hernandez-Echebarria, V. Sandoval, and J.L. Mostaza Cerebral ischemia as first manifestation of paroxysmal nocturnal hemoglobinuria Neurologia 22 2007 471 474
84. P.D. Ziakas, L.S. Poulou, and A. Pomoni Thrombosis in paroxysmal nocturnal hemoglobinuria at a glance: a clinical review Curr Vasc Pharmacol 6 2008 347 353
85. A.F. Scheuerle, N. Serbecic, and S.C. Beutelspacher Paroxysmal nocturnal hemoglobinuria may cause retinal vascular occlusions Int Ophthalmol 29 2009 187 190
86. S. Fujioka, and T. Asai Prognostic features of paroxysmal nocturnal hemoglobinuria in Japan Nippon Ketsueki Gakkai Zasshi 52 1989 1386 1394
87. L.H. Brubaker, L.J. Essig, and C.E. Mengel Neutrophil life span in paroxysmal nocturnal hemoglobinuria Blood 50 1977 657 662
88. D.V. Devine, R.S. Siegel, and W.F. Rosse Interactions of the platelets in paroxysmal nocturnal hemoglobinuria with complement. Relationship to defects in the regulation of complement and to platelet survival in vivo J Clin Invest 79 1987 131 137
89. J.G. Moore, R.K. Humphries, M.M. Frank, and N. Young Characterization of the hematopoietic defect in paroxysmal nocturnal hemoglobinuria Exp Hematol 14 1986 222 229
90. N. Iwamoto, T. Kawaguchi, K. Horikawa, S. Nagakura, T. Kagimoto, and T. Suda Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice Blood 87 1996 4944 4948
91. M.O. Elebute, S. Rizzo, J.A. Tooze, J.C. Marsh, E.C. Gordon-Smith, and F.M. Gibson Evaluation of the haemopoietic reservoir in de novo haemolytic paroxysmal nocturnal haemoglobinuria Br J Haematol 123 2003 552 560
92. J. Schubert, H.G. Vogt, M. Zielinska-Skowronek, M. Freund, J.P. Kaltwasser, and D. Hoelzer Development of the glycosylphosphatitylinositol- anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia Blood 83 1994 2323 2328
93. H. Schrezenmeier, B. Hertenstein, B. Wagner, A. Raghavachar, and H. Heimpel A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins Exp Hematol 23 1995 81 87
94. A. Griscelli-Bennaceur, E. Gluckman, M.L. Scrobohaci, P. Jonveaux, T. Vu, and A. Bazarbachi Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link Blood 85 1995 1354 1363
95. C. De Lord, J.A. Tooze, R. Saso, J.C. Marsh, and E.C. Gordon-Smith Deficiency of glycosylphosphatidyl inositol-anchored proteins in patients with aplastic anaemia does not affect response to immunosuppressive therapy Br J Haematol 101 1998 90 93
96. Y. Azenishi, E. Ueda, T. Machii, J. Nishimura, T. Hirota, and M. Shibano CD59-deficient blood cells and PIG-A gene abnormalities in Japanese patients with aplastic anaemia Br J Haematol 104 1999 523 529
97. D.E. Dunn, P. Tanawattanacharoen, P. Boccuni, S. Nagakura, S.W. Green, and M.R. Kirby Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes Ann Intern Med 131 1999 401 408
98. H. Wang, T. Chuhjo, H. Yamazaki, S. Shiobara, M. Teramura, and H. Mizoguchi Relative increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients: the high prevalence at diagnosis Eur J Haematol 66 2001 200 205
99. M. Iwanaga, K. Furukawa, T. Amenomori, H. Mori, H. Nakamura, and K. Fuchigami Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes Br J Haematol 102 1998 465 474
100. D.A. Sears, P.R. Anderson, A.L. Foy, H.L. Williams, and W.H. Crosby Urinary iron excretion and renal metabolism of hemoglobin in hemolytic diseases Blood 28 1966 708 725
101. M.E. Brecher, and H.F. Taswell Paroxysmal nocturnal hemoglobinuria and the transfusion of washed red cells A myth revisited. Transfusion 29 1989 681 685
102. J. Hirsh, B. Ungar, and J.S. Robinson Paroxysmal nocturnal haemoglobinuria: an acquired dyshaemopoiesis Australas Ann Med 13 1964 24 31
103. J.V. Dacie Transfusion of saline-washed red cells in nocturnal haemoglobinuria (Marchiafava-Micheli disease) Clin Sci (Lond) 7 1948 65 75
104. R.C. Hartmann, D.E. Jenkins Jr., L.C. McKee, and R.M. Heyssel Paroxysmal nocturnal hemoglobinuria: clinical and laboratory studies relating to iron metabolism and therapy with androgen and iron Medicine (Baltimore) 45 1966 331 363
105. C. Parker Eculizumab for paroxysmal nocturnal haemoglobinuria Lancet 373 2009 759 767
106. R.P. Rother, C.F. Mojcik, and E.W. McCroskery Inhibition of terminal complement: a novel therapeutic approach for the treatment of systemic lupus erythematosus Lupus 13 2004 328 334
107. R.P. Rother, S.A. Rollins, C.F. Mojcik, R.A. Brodsky, and L. Bell Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria Nat Biotechnol 25 2007 1256 1264 (Pubitemid 350076509)
108. P. Hillmen, C. Hall, J.C. Marsh, M. Elebute, M.P. Bombara, and B.E. Petro Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria N Engl J Med 350 2004 552 559
109. A. Hill, P. Hillmen, S.J. Richards, D. Elebute, J.C. Marsh, and J. Chan Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria Blood 106 2005 2559 2565
110. P. Hillmen, N.S. Young, J. Schubert, R.A. Brodsky, G. Socie, and P. Muus The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria N Engl J Med 355 2006 1233 1243
111. R.A. Brodsky, N.S. Young, E. Antonioli, A.M. Risitano, H. Schrezenmeier, and J. Schubert Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria Blood 111 2008 1840 1847 (Pubitemid 351451491)
112. J. Schubert, P. Hillmen, A. Roth, N.S. Young, M.O. Elebute, and J. Szer Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria Br J Haematol 142 2008 263 272 (Pubitemid 351987322)
113. AM Risitano, R Notaro, and L Marando Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab Blood 113 2009 4049 4100
114. E. Balleari, A.M. Gatti, C. Mareni, G. Massa, A.M. Marmont, and R. Ghio Recombinant human erythropoietin for long-term treatment of anemia in paroxysmal nocturnal hemoglobinuria Haematologica 81 1996 143 147
115. J. Schubert, C. Scholz, R.G. Geissler, A. Ganser, and R.E. Schmidt G-CSF and cyclosporin induce an increase of normal cells in hypoplastic paroxysmal nocturnal hemoglobinuria Ann Hematol 74 1997 225 230
116. J.G. Ray, R.F. Burows, J.S. Ginsberg, and E.A. Burrows Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient Haemostasis 30 2000 103 117
117. W.F. Rosse Treatment of paroxysmal nocturnal hemoglobinuria Blood 60 1982 20 23
118. M.F. McMullin, P. Hillmen, J. Jackson, P. Ganly, and L. Luzzatto Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria J Intern Med 235 1994 85 89
119. P.W. Sholar, and W.R. Bell Thrombolytic therapy for inferior vena cava thrombosis in paroxysmal nocturnal hemoglobinuria Ann Intern Med 103 1985 539 541
120. C. Hall, S. Richards, and P. Hillmen Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH) Blood 102 2003 3587 3591
121. P. Hillmen, P. Muus, U. Duhrsen, A.M. Risitano, J. Schubert, and L. Luzzatto Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria Blood 110 2007 4123 4128
122. A. Emadi, and R.A. Brodsky Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria Am J Hematol 84 2009 699 701
123. A.M. Stoppa, N. Vey, D. Sainty, C. Arnoulet, J. Camerlo, and M.A. Cappiello Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: absence of eradication of the PNH clone and dependence of response on cyclosporin A administration Br J Haematol 93 1996 42 44
124. R.L. Paquette, R. Yoshimura, C. Veiseh, L. Kunkel, J. Gajewski, and P.J. Rosen Clinical characteristics predict response to antithymocyte globulin in paroxysmal nocturnal haemoglobinuria Br J Haematol 96 1997 92 97
125. M.L. Graham, W.F. Rosse, E.C. Halperin, C.R. Miller, and R.E. Ware Resolution of Budd-Chiari syndrome following bone marrow transplantation for paroxysmal nocturnal haemoglobinuria Br J Haematol 92 1996 707 710
126. J.H. Antin, D. Ginsburg, B.R. Smith, D.G. Nathan, S.H. Orkin, and J.M. Rappeport Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment Blood 66 1985 1247 1250
127. R. Saso, J. Marsh, L. Cevreska, J. Szer, R.P. Gale, and P.A. Rowlings Bone marrow transplants for paroxysmal nocturnal haemoglobinuria Br J Haematol 104 1999 392 396
128. K. Kawahara, R.P. Witherspoon, and R. Storb Marrow transplantation for paroxysmal nocturnal hemoglobinuria Am J Hematol 39 1992 283 288
129. M. Endo, P.G. Beatty, T.M. Vreeke, C.T. Wittwer, S.P. Singh, and C.J. Parker Syngeneic bone marrow transplantation without conditioning in a patient with paroxysmal nocturnal hemoglobinuria: in vivo evidence that the mutant stem cells have a survival advantage Blood 88 1996 742 750
130. S. Buchholz, E. Dammann, C. Koenecke, M. Stadler, A. Franzke, and R. Blasczyk Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults-a single-centre experience Ann Hematol 87 2008 551 556